Search Results
You are looking at 1 - 1 of 1 items for
- Author: Fabrizio Monaco x
- Refine by access: All content x
Search for other papers by Cesidio Giuliani in
Google Scholar
PubMed
Search for other papers by Ines Bucci in
Google Scholar
PubMed
Search for other papers by Valeria Montani in
Google Scholar
PubMed
Search for other papers by Dinah S Singer in
Google Scholar
PubMed
Search for other papers by Fabrizio Monaco in
Google Scholar
PubMed
Search for other papers by Leonard D Kohn in
Google Scholar
PubMed
Search for other papers by Giorgio Napolitano in
Google Scholar
PubMed
Increased expression of major histocompatibility complex (MHC) class-I genes and aberrant expression of MHC class-II genes in thyroid epithelial cells (TECs) are associated with autoimmune thyroid diseases. Previous studies have shown that methimazole (MMI) reduces MHC class-I expression and inhibits interferon-γ (IFN-γ or IFNG as listed in the MGI Database)-induced expression of the MHC class-II genes in TECs. The action of MMI on the MHC class-I genes is transcriptional, but its mechanism has not been investigated previously. In the present study, we show that in Fisher rat thyroid cell line 5 cells, the ability of MMI and its novel derivative phenylmethimazole (C10) to decrease MHC class-I promoter activity is similar to TSH/cAMP suppression of MHC class-I and TSH receptor genes, and involves a 39 bp silencer containing a cAMP response element (CRE)-like site. Furthermore, we show that C10 decreases MHC class-I gene expression to a greater extent than MMI and at 10- to 50-fold lower concentrations. C10 also reduces the IFN-γ-induced increase in the expression of MHC class-I and MHC class-II genes more effectively than MMI. Finally, we show that in comparison to MMI, C10 is a better inhibitor of specific protein–DNA complexes that are formed with a CRE-like element on the MHC class-II promoter. These data support the conclusion that the immunosuppressive mechanism by which MMI and C10 inhibit MHC gene expression mimics ‘normal’ hormonal suppression by TSH/cAMP.
